Molecular pharmacology of chemokine receptor signalling in cancer

癌症趋化因子受体信号传导的分子药理学

• 批准号: nhmrc : GNT1088334
• 负责人: Dr Carl White
• 金额: $ 33.71万
• 依托单位国家: 澳大利亚
• 项目类别: Early Career Fellowships
• 财政年份: 2015
• 资助国家: 澳大利亚
• 起止时间: 2015-01-01 至 无数据
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/molecular-pharmacology-chemokine-signalling-cancer/1345728
• 关键词: Molecular; pharmacology; chemokine; receptor; signalling

Molecular pharmacology is the study of how hormones, neurotransmitters and pharmaceuticals interact with our cells through receptors, which transfer a signal across the cell membrane to change the function of that cell. Chemokine receptors are recognised to play a role in the development of many cancers. Understanding how these receptors work has enormous implications for improving our ability to develop better anti-cancer treatments with fewer side effects.

分子药理学是研究激素，神经递质和药物如何通过受体与我们的细胞相互作用，受体通过细胞膜传递信号来改变细胞的功能。趋化因子受体被认为在许多癌症的发展中起作用。了解这些受体的工作方式对于提高我们开发更好的抗癌治疗方法的能力具有巨大的意义，副作用更少。